|
Market Closed -
Nasdaq
01:00:00 03/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.420 USD | -6.58% |
|
-7.19% | -28.64% |
Company Valuation: Autolus Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 378.4 | 328.8 | 1,120 | 625.4 | 529.6 | 404.6 | - | - |
| Change | - | -13.12% | 240.67% | -44.17% | -15.31% | -23.61% | - | - |
| Enterprise Value (EV) 1 | 68.11 | -53.95 | 879.8 | 89.99 | 300.3 | 252.2 | 329.5 | 345.6 |
| Change | - | -179.21% | 1,730.86% | -89.77% | 233.7% | -16.01% | 30.63% | 4.89% |
| P/E | -2.63x | -1.21x | -5.37x | -2.73x | -1.84x | -1.87x | -2.2x | -2.58x |
| PBR | 1.51x | 1.1x | 10x | 1.46x | 2.97x | - | - | - |
| PEG | - | 0.1x | 0.2x | 0.1x | -0.1x | 0.1x | 0.2x | 0.2x |
| Capitalization / Revenue | 162x | 51.7x | 660x | 61.8x | 7.03x | 2.7x | 2.1x | 1.44x |
| EV / Revenue | 29.2x | -8.48x | 518x | 8.89x | 3.98x | 1.68x | 1.71x | 1.23x |
| EV / EBITDA | -0.44x | 0.35x | -5.08x | -0.39x | -1.15x | -1.26x | -1.92x | -4x |
| EV / EBIT | -0.42x | 0.33x | -4.9x | -0.37x | -1.11x | -1.27x | -2.05x | -2.73x |
| EV / FCF | -0.54x | 0.44x | -5.62x | -0.39x | -0.99x | -2.08x | -3.09x | -5.33x |
| FCF Yield | -186% | 228% | -17.8% | -254% | -101% | -48.1% | -32.4% | -18.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.97 | -1.57 | -1.2 | -0.86 | -1.08 | -0.8108 | -0.6922 | -0.5891 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2.33 | 6.36 | 1.698 | 10.12 | 75.39 | 149.8 | 192.4 | 281.2 |
| EBITDA 1 | -154.2 | -154.3 | -173.1 | -233.7 | -260.7 | -200.6 | -171.6 | -86.5 |
| EBIT 1 | -162.7 | -161.7 | -179.7 | -241.4 | -270.5 | -198.6 | -160.5 | -126.6 |
| Net income 1 | -142.1 | -148.8 | -208.4 | -220.7 | -287.5 | -219.9 | -187.5 | -125.4 |
| Net Debt 1 | -310.3 | -382.8 | -240.3 | -535.4 | -229.3 | -152.4 | -75.11 | -58.99 |
| Reference price 2 | 5.190 | 1.900 | 6.440 | 2.350 | 1.990 | 1.520 | 1.520 | 1.520 |
| Nbr of stocks (in thousands) | 72,919 | 173,059 | 173,937 | 266,122 | 266,143 | 266,163 | - | - |
| Announcement Date | 10/03/22 | 07/03/23 | 14/03/24 | 20/03/25 | 27/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.87x | 1.68x | -1.26x | - | 405M | |
| 41.42x | 14.01x | 31.06x | 0.48% | 1,263B | |
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | |
| 36.71x | 8.6x | 17.71x | 2.35% | 521B | |
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | |
| 97.38x | 6.07x | 25.8x | 2.28% | 369B | |
| 23.19x | 5.95x | 14.36x | 2.69% | 307B | |
| 24.47x | 4.89x | 13.87x | 1.77% | 290B | |
| 29.55x | 7.53x | 13.48x | 2.16% | 252B | |
| -40.86x | 7.45x | 46.76x | 1.94% | 212B | |
| Average | 27.17x | 6.82x | 19.38x | 2.01% | 426.23B | |
| Weighted average by Cap. | 36.40x | 8.82x | 22.82x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AUTL Stock
- Valuation Autolus Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
